Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis-Reference-Cited by-同舟云学术

Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis

Published:2023-09-30 Issue:12 Volume:40 Page:5547-5556
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Rau Daniela^ORCID,Müller Beate,Übler Susanne

Funder

INTERCOMPANY

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02682-z.pdf

Reference28 articles.

1. D’Amico E, Haase R, Ziemssen T. Review: Patient-reported outcomes in multiple sclerosis care. Mult Scler Relat Disord. 2019;33:61–6. https://doi.org/10.1016/j.msard.2019.05.019.

2. Nowinski CJ, Miller DM, Cella D. Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials. Neurotherapeutics. 2017;14(4):934–44. https://doi.org/10.1007/s13311-017-0571-6.

3. Lee MK, Schalet BD, Cella D, Yost KJ, Dueck AC, Novotny PJ, et al. Establishing a common metric for patient-reported outcomes in cancer patients: Linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Patient Rep Outcomes. 2020;4(1):106. https://doi.org/10.1186/s41687-020-00271-0.

4. Kamudoni P, Johns J, Cook KF, Salem R, Salek S, Raab J, et al. A comparison of the measurement properties of the PROMIS Fatigue (MS) 8a against legacy fatigue questionnaires. Mult Scler Relat Disord. 2022;66:104048. https://doi.org/10.1016/j.msard.2022.104048.

5. Kamudoni P, Johns J, Cook KF, Salem R, Salek S, Raab J, et al. Standardizing fatigue measurement in multiple sclerosis: The validity, responsiveness and score interpretation of the PROMIS SF v1.0—Fatigue (MS) 8a. Mult Scler Relat Disord. 2021;54:103117. https://doi.org/10.1016/j.msard.2021.103117.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event;Frontiers in Neurology;2024-06-20

2. Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France;Neurology and Therapy;2024-03-15